Parental decision making regarding treatment of hypoplastic left heart syndrome

Marcia K Ellinger1, Gwen R Rempel

  • 1Alberta Health Services, Northern Alberta Neonatal Intensive Care Program, Edmonton, Alberta, Canada.

Insights

Parents navigating hypoplastic left heart syndrome (HLHS) decisions found the Norwood-Sano surgery option complex. Understanding their experiences offers insights into choosing treatment for complex congenital heart anomalies.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Surgical Outcomes

Background:

  • Hypoplastic left heart syndrome (HLHS) presents complex treatment choices for parents, including palliative care, surgery, or transplantation.
  • Antenatal diagnosis adds the decision of pregnancy continuation.
  • Healthcare providers have varied opinions on counseling options, with less research on parental perspectives.

Purpose of the Study:

  • To explore parents' experiences and decision-making processes when choosing the Norwood-Sano surgical option for HLHS.
  • To understand the treatment options presented to parents following an HLHS diagnosis.
  • To gain insight into how parents arrived at their decision for surgical palliation.

Main Methods:

  • Qualitative analysis of interview data from parents of children with HLHS.
  • Focus on parents who selected the Norwood-Sano surgical approach.
  • Exploration of the counseling and decision-making journey.

Main Results:

  • Parents' perspectives on treatment options for HLHS are less understood than healthcare providers'.
  • The study provides insight into the parental decision-making process for complex congenital heart anomaly treatment.
  • Understanding parental choice factors for the Norwood-Sano option.

Conclusions:

  • Parental experiences and perspectives are crucial in understanding treatment decisions for HLHS.
  • Further research into parental decision-making can inform counseling strategies.
  • The study highlights the importance of considering parental viewpoints in pediatric cardiac care.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...